Concepedia

Steven J. Nicol

SJ

Statistics

Publications

17

Citations

1.2K

H-Index

16

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Vanderbilt University Medical Center

Johns Hopkins University

Neurological Surgery

Roswell Park Comprehensive Cancer Center

Steven J. Nicol is an author at Eli Lilly (United States) specializing in oncology, medicine, and chemotherapy.

Publications per year

1998–2019

17

Publications

17

Phase II Trial of Gemcitabine Plus Cisplatin in Patients With Metastatic Urothelial Cancer

Derek Raghavan, Michael A. Carducci, Ellis Levine et al. · Journal of Clinical Oncology · 2000 · 262 citations

, , +17

Phase II Study of Pemetrexed for Second-Line Treatment of Transitional Cell Cancer of the Urothelium

Christopher J. Sweeney, Bruce J. Roth, Fairooz F. Kabbinavar et al. · Journal of Clinical Oncology · 2006 · 245 citations

, , +17

Full-Dose Gemcitabine With Concurrent Radiation Therapy in Patients With Nonmetastatic Pancreatic Cancer: A Multicenter Phase II Trial

William Small, Jordan Berlin, Gary M. Freedman et al. · Journal of Clinical Oncology · 2008 · 150 citations · Full text

, , +17

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Nicholas Butowski, Susan M. Chang, Kathleen R. Lamborn et al. · Neuro-Oncology · 2011 · 77 citations · Full text

, , +17

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

Mace L. Rothenberg, A. Sharma, Geoffrey R. Weiss et al. · Annals of Oncology · 1998 · 76 citations

, , +10

1–5 of 17